Market Place
Sourcing Support
Enforcement Report - Week of November 27, 2024
27 Nov 2024 //
FDA
Lupin receives FDA approval for generic version of Adderall XR
21 Nov 2024 //
EXPRESSPHARMA
US charges executives at ADHD startup in Adderall fraud
13 Jun 2024 //
REUTERS
Enforcement Report - Week of February 7, 2024
07 Feb 2024 //
FDA
Drug mix-up prompts Azurity to recall 1 lot of Zenzedi
26 Jan 2024 //
FIERCE PHARMA
Lawmakers push FDA, DEA for update amid Adderall shortage
13 Oct 2023 //
FIERCE PHARMA
Glenmark and Cediprof announce exclusive distribution agreement in US
09 Mar 2023 //
ECONOMIC TIMES
Granules Pharma Receives ANDA Approval for Amphetamine Mixed Salts ER Capsules
24 Jan 2023 //
PRESS RELEASE
Granules gets USFDA`s nod for Amphetamine capsules
24 Jan 2023 //
ECONOMIC TIMES
XELSTRYM transdermal system, CII, to be revealed as available soon at APSARD
10 Jan 2023 //
PR NEWSWIRE
FDA`s drug shortages leader wants companies to start reporting increases
02 Dec 2022 //
ENDPTS
Tris Pharma Announces Continued Supply and Availability of DYANAVEL Tablets
19 Oct 2022 //
PRNEWSWIRE
Enforcement Report - Week of September 21, 2022
21 Sep 2022 //
FDA
Tris`s Generic Dextroamphetamine Sulfate Receives Approval in the U.S.
18 Aug 2022 //
FDA
Tris Pharma Announces Availability of New DYANAVEL XR Tablets for ADHD
16 Aug 2022 //
PRNEWSWIRE
Teva runs into Adderall supply hitch as ADHD diagnoses mount
03 Aug 2022 //
FIERCEPHARMA
Tris Pharma Announces Publication of Study Results of DYANAVEL XR in ADHD
22 Jul 2022 //
PRNEWSWIRE
FDA warns websites illegally selling ADHD drug Adderall
13 Apr 2022 //
REUTERS
FDA warns websites illegally selling ADHD drug Adderall
12 Apr 2022 //
REUTERS
Vallon`s abuse-resistant Adderall fails clinical trial; stocks plunge 70%
23 Mar 2022 //
BIZJOURNALS
Granules Pharma receives ANDA approval for Amphetamine mixed salts from US FDA
30 Dec 2021 //
EXPRESS PHARMA
ADHD drug developer Cingulate sets terms for $50 million IPO
27 Sep 2021 //
RENAISSANCECAPITAL
Rhodes Pharms`s Generic Amphetamine Sulphate Receives Approval in the US
07 Sep 2021 //
FDA
Winder Labs Llc`s Generic Dextroamphetamine Sulfate Receives Approval In US
07 Jun 2021 //
FDA
Noven to Present Pivotal Study Results for Investigational Dextroamphetamine
27 Apr 2021 //
BUSINESSWIRE
Ascent`s Generic Amphetamine ; Dextroamphetamine Receives Approval In US
22 Apr 2021 //
FDA
Noven Submits New Drug Application for Investigational Dextroamphetamine
22 Feb 2021 //
BUSINESSWIRE
RECORDATI: LICENSE OBTAINED FOR THE COMMERCIALIZATION OF ELIGARD IN EUROPE
29 Jan 2021 //
GLOBENEWSWIRE
Sun Pharm`s Generic Amphetamine Sulfate Receives Approval In US
29 Jan 2021 //
FDA
RECORDATI RARE DISEASES: CARBAGLU® 200mg Receives U.S. FDA Approval
26 Jan 2021 //
PRNEWSWIRE
Tris Pharma Presents Positive Results from Phase 3 Study of Amphetamine
20 Jan 2021 //
PRNEWSWIRE
Tris Pharma to Debut Amphetamine Extended-Release Tablet Efficacy
15 Jan 2021 //
PRNEWSWIRE
Tris Pharma to Present Amphetamine Extended-Release Tablet Data
22 Oct 2020 //
PRNEWSWIRE
Tris Pharma to Present Amphetamine Extended-Release Tablet Data
21 Oct 2020 //
PRNEWSWIRE
Riconpharma`s Generic Amphetamine Sulfate Receives Approval in US
27 Aug 2020 //
FDA
Recordati: Positive Results From the PH III LINC-3 Study of Isturisa®
27 Jul 2020 //
BUSINESSWIRE
Mayne Pharma’s Generic Amphetamine Sulfate Receives Approval In US
18 Jul 2020 //
FDA
Enforcement Report - Week of June 10, 2020
10 Jun 2020 //
FDA
Recordati Rare Diseases Announces First European Launch of Isturisa®
02 Jun 2020 //
BUSINESSWIRE
Havix`s Generic Amphetamine Sulfate Receives Approval In US
28 May 2020 //
FDA
Recordati Rare Diseases Inc. Announces Availability of ISTURISA®
26 May 2020 //
BUSINESSWIRE
Dr. Reddy`s Laboratories announces the launch of Amphetamine Sulfate Tablets
13 Apr 2020 //
BUSINESSWIRE
Recordati Rare Diseases now holds Isturisa® European MA
08 Apr 2020 //
GLOBENEWSWIRE
Prinston Inc Generic Amphetamine Sulfate Receives Approval in US
17 Mar 2020 //
FDA
Cerovene`s Generic Amphetamine sulphate Receives Approval in US
06 Feb 2020 //
FDA
Enforcement Report - Week of October 23, 2019
24 Oct 2019 //
FDA
French weight-loss pill scandal set for landmark trial
21 Sep 2019 //
REUTERS
FDA Consults on Abuse-Deterrent CNS Stimulants
20 Sep 2019 //
RAPS
Granules Pharm`s Generic Amphetamine sulphate Receives Approval In US
09 Aug 2019 //
FDA
USFDA nod for Granules’ ANDA
06 Aug 2019 //
THEHINDU
Lannett Company launches generic Adderall
16 May 2019 //
PHARMABIZ
FDA Drafts Guidance for Developing Drugs to Treat ADHD
06 May 2019 //
RAPS
Aurolife Pharma `s Generic Amphetamine Sulfate Receives Approval in US
19 Apr 2019 //
FDA
